21.05.2015 - Johnson & Johnson's Janssen Pharmaceuticals offshoot has told analysts it plans to seek regulatory approval for more than 10 new drugs up to 2019, each with the potential to...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)